Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Veblocema 120 mg" (15)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Infliximab (L04AB02) 15 products
WHO-DDD
DrugBank.ca
L
IP
CI
Veblocema 120 mg
532.11
627.85
10 %
Injection solution in prefilled syringe: Infliximabum 120 mg/ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
Remicade
Durchstechflasche(n)
525.40
620.15
10 %
Lyophilisate: Infliximabum 100 mg
MSD Merck Sharp &
Dohme AG
A / SL
FB
G
L
IP
Inflectra 100 mg
Durchstechflasche(n)
495.81
586.15
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Infliximabum 100 mg
Pfizer AG
A / SL
FB
G
L
IP
Remicade 100 mg
468.27
554.50
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Infliximabum 100 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A / SL
FB
G
L
IP
Remsima 100 mg
452.29
536.15
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Infliximabum 100 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A / SL
FB
G
L
IP
Remsima 100 mg
Durchstechflasche(n)
495.81
586.15
10 %
poudre pour un concentré destiné à la préparation d'une solution pour perfusion: Infliximabum 100 mg
iQone Healthcare
Switzerland SA
A / SL
FB
G
IP
CI
Veblocema 120 mg
2
PR
PR
k.A.
Injection solution in prefilled syringe: Infliximabum 120 mg/ml
iQone Healthcare
Switzerland SA
A
FB
G
IP
CI
Veblocema 120 mg
4
PR
PR
k.A.
Injection solution in prefilled syringe: Infliximabum 120 mg/ml
iQone Healthcare
Switzerland SA
A
FB
G
IP
Remicade 100 mg
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Infliximabum 100 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
Remicade 100 mg
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Infliximabum 100 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
Remsima 100 mg
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Infliximabum 100 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
Remsima 100 mg
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Infliximabum 100 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
Veblocema
PR
PR
k.A.
solution injectable en seringue préremplie: Infliximabum 120 mg/ml
iQone Healthcare
Switzerland SA
A
FB
G
IP
Veblocema
2
PR
PR
k.A.
solution injectable en seringue préremplie: Infliximabum 120 mg/ml
iQone Healthcare
Switzerland SA
A
FB
G
IP
Veblocema
4
PR
PR
k.A.
solution injectable en seringue préremplie: Infliximabum 120 mg/ml
iQone Healthcare
Switzerland SA
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
